Gene · 2248
Papers2,103
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,103
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinical, imaging, and molecular features of radiation-induced glioblastomas developing more than 20 years after radiation therapy for intracranial germinomatous germ cell tumor: illustrative cases. | J Neurosurg Case Lessons | 2023 | 37870755 | PubTator, text mining | PubMed |
| Fibroblast growth factor signaling in axons: from development to disease. | Cell Commun Signal | 2023 | 37845690 | PubTator, text mining | PubMed |
| Next-generation sequencing in dermatology. | Front Med (Lausanne) | 2023 | 37841001 | PubTator, text mining | PubMed |
| Catalytic 4-exo-dig carbocyclization for the construction of furan-fused cyclobutanones and synthetic applications. | Nat Commun | 2023 | 37821471 | PubTator, text mining | PubMed |
| Next-generation sequencing improves precision medicine in hearing loss. | Front Genet | 2023 | 37811145 | PubTator, text mining | PubMed |
| ARGem: a new metagenomics pipeline for antibiotic resistance genes: metadata, analysis, and visualization. | Front Genet | 2023 | 37811141 | PubTator, text mining | PubMed |
| A five-carbon unsaturated Criegee intermediate: synthesis, spectroscopic identification, and theoretical study of 3-penten-2-one oxide. | Chem Sci | 2023 | 37800006 | PubTator, text mining | PubMed |
| Pure Interstitial Trisomy 11q Arising from a Nonrecurrent 11q13.1q22.3 Mosaic Intrachromosomal Duplication in a Patient with Craniofacial Dysmorphism and Genital Anomalies. | Mol Syndromol | 2023 | 37766825 | PubTator, text mining | PubMed |
| Sensitive HIV-1 DNA Pol Next-Generation Sequencing for the Characterisation of Archived Antiretroviral Drug Resistance. | Viruses | 2023 | 37766218 | PubTator, text mining | PubMed |
| FGFR families: biological functions and therapeutic interventions in tumors. | MedComm (2020) | 2023 | 37750089 | PubTator, text mining | PubMed |
| Genomic Variations in Esophageal Squamous Cell Carcinoma and Esophageal Adenocarcinoma. | Cureus | 2023 | 37745740 | PubTator, text mining | PubMed |
| Aberrant gene activation in synovial sarcoma relies on SSX specificity and increased PRC1.1 stability. | Nat Struct Mol Biol | 2023 | 37735617 | PubTator, text mining | PubMed |
| 'Thank goodness you're here'. Exploring the impact on patients, family carers and staff of enhanced 7-day specialist palliative care services: A mixed methods study. | Palliat Med | 2023 | 37731382 | PubTator, text mining | PubMed |
| Variable Ca-Caryl Hapticity and its Consequences in Arylcalcium Dimers. | Adv Sci (Weinh) | 2023 | 37715248 | PubTator, text mining | PubMed |
| LRRC59 serves as a novel biomarker for predicting the progression and prognosis of bladder cancer. | Cancer Med | 2023 | 37706625 | PubTator, text mining | PubMed |
| Synthesis of metalla-dual-azulenes with fluoride ion recognition properties. | Nat Commun | 2023 | 37696902 | PubTator, text mining | PubMed |
| Differences in the Clinical and Molecular Profiles of Subungual Melanoma and Acral Melanoma in Asian Patients. | Cancers (Basel) | 2023 | 37686691 | PubTator, text mining | PubMed |
| Potential Predictive Biomarkers of Systemic Drug Therapy for Hepatocellular Carcinoma: Anticipated Usefulness in Clinical Practice. | Cancers (Basel) | 2023 | 37686621 | PubTator, text mining | PubMed |
| Emerging systemic therapy options beyond CDK4/6 inhibitors for hormone receptor-positive HER2-negative advanced breast cancer. | NPJ Breast Cancer | 2023 | 37684290 | PubTator, text mining | PubMed |
| Fibroblast growth factor receptors as targets for anticancer therapy in cholangiocarcinomas and urothelial carcinomas. | Heliyon | 2023 | 37681152 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2248/papers?page=7